Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bobin Chen

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Internal Medicine (Tokyo, Japan)|September 20, 2012
Clinical features of 66 lymphoma patients presenting with a fever of unknown originJing Zhang, Bobin Chen, Xiaoping Xu, et al.
Case Reports in Medicine|January 31, 2017
Polyneuropathy as Novel Initial Manifestation in a Case of "Nonsecretory" POEMS Syndrome with Sjögren's SyndromeMinrui Liang, Zhixing Jiang, Zhiguang Lin, et al.
Annals of Hematology|February 25, 2026
Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphomaQing Li, Lili Zhu, Yan Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2009
Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinomaTulin Budak-Alpdogan, Bobin Chen, Anjali Warrier, et al.
Frontiers in Oncology|May 14, 2023
Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphomaYu Yang, Qing Li, Jingjing Ma, et al.
Frontiers in Immunology|July 10, 2023
Prognostic impact of peripheral natural killer cells in primary central nervous system lymphomaZhiguang Lin, Jingjing Ma, Yan Ma, et al.
Molecular Therapy Oncolytics|June 6, 2022
Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regimeCanjing Zhang, Huiwen Xu, Xianxian Sui, et al.
Journal of Neuro-Oncology|June 22, 2022
A prospective cohort study of methotrexate plus idarubicin in newly diagnosed primary CNS lymphomaQing Li, Yan Ma, Zhiguang Lin, et al.
Hematology (Amsterdam, Netherlands)|August 7, 2023
Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphomaZhiguang Lin, Huiwen Xu, Jingjing Ma, et al.
Annals of Hematology|February 8, 2019
The role of ABCB1 polymorphism as a prognostic marker for primary central nervous system lymphomaTing Wu, Hui Kang, Dongxiao Zhuang, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Internal Medicine (Tokyo, Japan)|September 20, 2012
Clinical features of 66 lymphoma patients presenting with a fever of unknown originJing Zhang, Bobin Chen, Xiaoping Xu, et al.
Case Reports in Medicine|January 31, 2017
Polyneuropathy as Novel Initial Manifestation in a Case of "Nonsecretory" POEMS Syndrome with Sjögren's SyndromeMinrui Liang, Zhixing Jiang, Zhiguang Lin, et al.
Annals of Hematology|February 25, 2026
Superiority of high-dose cytarabine-based mobilisation over cyclophosphamide or plerixafor in primary CNS lymphomaQing Li, Lili Zhu, Yan Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2009
Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinomaTulin Budak-Alpdogan, Bobin Chen, Anjali Warrier, et al.
Frontiers in Oncology|May 14, 2023
Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphomaYu Yang, Qing Li, Jingjing Ma, et al.
Frontiers in Immunology|July 10, 2023
Prognostic impact of peripheral natural killer cells in primary central nervous system lymphomaZhiguang Lin, Jingjing Ma, Yan Ma, et al.
Molecular Therapy Oncolytics|June 6, 2022
Icaritin inhibits PLK1 to activate DNA damage response in NK/T cell lymphoma and increases sensitivity to GELOX regimeCanjing Zhang, Huiwen Xu, Xianxian Sui, et al.
Journal of Neuro-Oncology|June 22, 2022
A prospective cohort study of methotrexate plus idarubicin in newly diagnosed primary CNS lymphomaQing Li, Yan Ma, Zhiguang Lin, et al.
Hematology (Amsterdam, Netherlands)|August 7, 2023
Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphomaZhiguang Lin, Huiwen Xu, Jingjing Ma, et al.
Annals of Hematology|February 8, 2019
The role of ABCB1 polymorphism as a prognostic marker for primary central nervous system lymphomaTing Wu, Hui Kang, Dongxiao Zhuang, et al.
Pageof 7